Walter S Speidl Selected Research

Walter S Speidl Research Topics

Disease

14	Inflammation (Inflammations) 01/2024 - 08/2003
13	Myocardial Infarction 01/2023 - 11/2005
12	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 09/2002
11	Atherosclerosis 07/2023 - 11/2005
10	Critical Illness (Critically Ill) 06/2022 - 12/2015
9	Atherosclerotic Plaque (Atheroma) 01/2022 - 12/2002
6	Heart Failure 01/2022 - 02/2015
5	Cardiovascular Diseases (Cardiovascular Disease) 07/2023 - 12/2006
4	Cardiogenic Shock 04/2024 - 01/2019
4	Thrombosis (Thrombus) 01/2024 - 01/2008
4	Acute Coronary Syndrome 01/2024 - 06/2016
4	Infarction (Infarctions) 01/2024 - 11/2019
4	Hypoxia (Hypoxemia) 08/2020 - 09/2003
4	Stable Angina 06/2014 - 06/2004
3	Sepsis (Septicemia) 01/2022 - 12/2006
3	Heart Arrest (Cardiac Arrest) 01/2021 - 10/2019
3	Endotoxemia 09/2019 - 04/2005
3	Necrosis 02/2015 - 06/2007
2	Infections 04/2024 - 01/2022
2	Disseminated Intravascular Coagulation 04/2024 - 01/2020
2	Shock 04/2024 - 01/2024
2	Myocarditis (Carditis) 04/2024 - 09/2003
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2024 - 01/2018
2	Fibrosis (Cirrhosis) 10/2017 - 11/2009
2	Non-ST Elevated Myocardial Infarction 06/2014 - 01/2014
2	Neointima 06/2014 - 11/2013
2	ST Elevation Myocardial Infarction 06/2014 - 01/2014
1	Thrombocytopenia (Thrombopenia) 04/2024
1	Drug-Related Side Effects and Adverse Reactions 04/2024
1	Hypotension (Low Blood Pressure) 04/2024
1	Ventricular Fibrillation 01/2024
1	Out-of-Hospital Cardiac Arrest 01/2024
1	Tachycardia (Tachyarrhythmias) 06/2022
1	Ventricular Tachycardia 06/2022
1	Septic Shock (Toxic Shock Syndrome) 01/2022
1	Angina Pectoris 01/2021
1	Fabry Disease (Fabry's Disease) 01/2021
1	Left Ventricular Dysfunction 01/2021

Drug/Important Bio-Agent (IBA)

8	CytokinesIBA 01/2021 - 06/2006
6	C-Reactive ProteinIBA 01/2024 - 09/2002
6	Biomarkers (Surrogate Marker)IBA 01/2024 - 10/2019
4	Lipoprotein(a)IBA 01/2020 - 06/2004
3	oxidized low density lipoproteinIBA 01/2022 - 08/2013
3	Interleukin-33IBA 01/2018 - 01/2014
3	Clopidogrel (Plavix)FDA Link 01/2018 - 01/2008
3	Matrix Metalloproteinases (MMPs)IBA 10/2017 - 03/2004
3	CholesterolIBA 11/2015 - 09/2009
3	LipidsIBA 11/2015 - 03/2008
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2014 - 09/2003
3	Apolipoprotein A-I (Apolipoprotein A1)IBA 09/2009 - 03/2008
2	ApolipoproteinsIBA 07/2023 - 01/2023
2	pro-brain natriuretic peptide (1-76)IBA 01/2021 - 08/2020
2	EnzymesIBA 01/2021 - 09/2009
2	Brain Natriuretic Peptide (Natrecor)FDA Link 08/2020 - 11/2009
2	Mitochondrial DNA (mtDNA)IBA 08/2020 - 12/2015
2	Proteins (Proteins, Gene)FDA Link 09/2019 - 01/2019
2	Adenosine Diphosphate (ADP)IBA 01/2018 - 01/2017
2	Plasminogen Activator Inhibitor 1IBA 10/2017 - 01/2008
2	Simendan (Levosimendan)IBA 01/2017 - 02/2015
2	Lipoproteins (Lipoprotein)IBA 11/2015 - 01/2015
2	Triglycerides (Triacylglycerol)IBA 11/2015 - 05/2012
2	omega-Chloroacetophenone (Mace)IBA 01/2015 - 11/2005
2	HDL LipoproteinsIBA 12/2014 - 11/2009
2	apolipoprotein A-I MilanoIBA 08/2010 - 03/2008
2	Oncostatin MIBA 09/2009 - 03/2008
2	AntigensIBA 02/2007 - 08/2003
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2006 - 04/2005
1	Heparin (Liquaemin)FDA LinkGeneric 04/2024
1	Azithromycin (Zithromax)FDA LinkGeneric 04/2024
1	LDL CholesterolIBA 07/2023
1	Apolipoproteins E (ApoE)IBA 01/2023
1	Toll-Like Receptor 9IBA 01/2023
1	landiololIBA 06/2022
1	Neprilysin (Neutral Endopeptidase)IBA 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	Ranolazine FDA Link 01/2022
1	Interferon Type IIBA 01/2022
1	Neurofibromin 2 (Merlin)IBA 01/2022
1	Bacterial LysatesIBA 01/2022
1	Proprotein Convertase 9IBA 05/2021
1	Vasodilator Agents (Vasodilators)IBA 01/2021
1	Nicorandil (SG 75)IBA 01/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2021
1	GalactosidasesIBA 01/2021
1	Coenzyme A (CoA)IBA 01/2021
1	Trimetazidine (Vastarel)IBA 01/2021
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 01/2021
1	NF-kappa B (NF-kB)IBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	Natriuretic PeptidesIBA 01/2021
1	InflammasomesIBA 01/2021
1	globotriaosylceramide (globotriosylceramide)IBA 01/2021

Therapy/Procedure

7	Therapeutics 04/2024 - 06/2016
7	Percutaneous Coronary Intervention 01/2024 - 11/2005
4	Stents 01/2024 - 01/2008
2	Extracorporeal Membrane Oxygenation 04/2024 - 01/2024
2	Cardiopulmonary Resuscitation (CPR) 01/2024 - 06/2013
2	Drug-Eluting Stents 01/2021 - 01/2020
1	Intravenous Administration 04/2024
1	Aftercare (After-Treatment) 01/2021